When: RSI bullish divergence at oversold

Then: Reassess Underweight thesis

When: Forward EPS reaffirmation at $6.00+ with Nutrition stabilization

Then: Reassess Underweight thesis

SELL; Trim into relief rally around 105 area, do not chase bounce at 100, maintain reduced exposure into Q3; speculative long sized to 50% of normal is acceptable as defined-risk participation; wait for confirmation (close above 200 SMA with conviction, successful retest of lows as support, or clean Q3 print with raised guidance) before adding fresh long exposure

• 28% drawdown in nine sessions does not happen in a vacuum; prudent read is someone with better information is repricing risk
• TTM revenue of 46.58 billion and free cash flow of 7.21 billion are forward-looking bets that can break
• Forward EPS of 6.07 dollars assumes Exact Sciences-style integration hits synergies and targets
• Trader applied proper 2x ATR stop discipline at 95.35 as standard institutional framework
• Aggressive analyst's stop at 96.49 tightens risk by accepting worse exit under Oct 1 swing low
• Stretch target of 115 to 120 requires complete trend reversal, MAs to flip back to support, and clean Q3 print
• Net debt went from 4.4 billion to 27.2 billion in one quarter - permanent change in risk profile
• Ratings agencies have already put ABT on watch; any synergy miss could trigger downgrade raising refinancing costs
• Forward P/E of 16.5x prices in skepticism; further skepticism is also priced in
• Consensus EPS estimates have history of getting cut after debt-financed deals close
• 10 EMA at 100.14, 50 SMA at 106.78, 200 SMA at 103.02 all overhead resistance
• Q3 earnings loom in roughly 10 sessions
• Single-candle reversals in confirmed downtrends fail more often than they succeed, particularly with binary earnings catalyst
• Speculative long sized to 50% of normal is acceptable as defined-risk participation

→ vs aggressive: The 'liquidity event' framing of the 28% drawdown is dangerous; a 28% move in nine sessions does not happen in vacuum and likely signals informed repricing

→ vs aggressive: The R:R math is goalpost-shifting; moving stop to 96.49 and using stretch targets of 115-120 manufactures a favorable ratio that won't survive pre-earnings volatility

→ vs aggressive: The '70% win rate bounce' argument uses broad market statistics inapplicable to confirmed downtrends with overhead resistance and binary earnings risk

→ vs aggressive: The leverage argument omits that net debt went from 4.4 billion to 27.2 billion in one quarter, permanently changing the firm's risk profile

→ vs aggressive: The Q3 'low bar' assumption ignores that healthcare Q3 prints have been brutal recently; a miss at these levels gets sold, not bought

Partial trim of one-third to one-half into $103-$105, maintaining 50% of normal position size with stop at $96.50

• Trader has existing position looking to trim at $105 on relief rally, stop at $103
• Aggressive analyst's 70% win rate on lower-band bounces applies to stable uptrends, not confirmed downtrends
• Aggressive analyst's $115-$120 target implies regime change requiring all three MAs to flip support
• Conservative analyst incorrectly anchored R:R math to $95.35 stop; actual stop is $103
• Conservative analyst's 'wait for 200 SMA confirmation' framework would miss entire bounce as 200 SMA sits only 2.9% above current levels at $103.02
• Dividend yield of 2.58% provides hard floor in income-oriented accounts
• Forward P/E of 16.5x prices in significant integration skepticism already
• $7B in FCF and aristocrat dividend on defensive franchise doesn't trade at $85 without fundamental breakdown
• Recommended action: reduce exposure by one-third to one-half into $103-$105 rally
• Maintain core position sized to 50% of normal with stop at $96.50 (just under Oct 1 swing low)
• New targets on core position: 200 SMA at $103.02 and 50 SMA at $106.78, contingent on Q3 earnings confirmation
• ATR of 2.37 and Q3 binary event risk (ten sessions away) warrant reduced position sizing

→ vs aggressive: 70% win rate on lower-band-tag bounces is a category error when applied to a stock in confirmed intermediate-term downtrend with all major MAs overhead

→ vs aggressive: $115-$120 stretch target implies regime change, not tactical bounce; conflating the two manufactures a 6-to-1 R:R that requires goalpost-shifting

→ vs aggressive: Underestimating Q3 binary risk by assuming benign outcome to known catalyst is the single most dangerous assumption with firm capital

→ vs conservative: Using $95.35 stop (2x ATR for context) rather than actual $103 stop artificially compresses trader's favorable setup into something unfavorable

→ vs conservative: 'Wait for confirmation above 200 SMA' framework would miss entire bounce then chase at $110 after confirmation arrives

→ vs conservative: Worst-case framing ignores that $7B FCF, dividend aristocrat status, and 16.5x forward P/E create a cash flow floor that prevents $85 collapse absent fundamental break